Speaking at the Milken Institute's annual Global Conference, Amgen CEO Bob Bradway hailed dramatic advances in drug discovery made possible by the convergence of "biotech" and "tech," but also warned of threats to the ecosystem in the U.S. that has long nurtured innovation. [...]

This is an abstract of the document. To keep reading, click here and get access to the original version.

Attachments

  • Original Link
  • Permalink

Disclaimer

Amgen Inc. published this content on 20 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 May 2024 21:31:57 UTC.